Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2.
Hsiao-Ling ChiangKang-Hao LiangRuei-Min LuTing-Wen KuoYi-Ling LinHan-Chung WuPublished in: Journal of biomedical science (2023)
Thus, our efficient screening of BA.5-specific neutralizing hAbs from breakthrough infectious convalescent donors successfully yielded hAbs with potent therapeutic potential against multiple SARS-CoV-2 variants.